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Tissue engineers are often confused on ﬁnding the most successful strategy for speciﬁc patient. In this study, we used artiﬁcial
neural networks to predict the outcomes of diﬀerent vascular tissue engineering strategies, thus providing advisory information
for experimental designers. Over 30 variables were used as features of the tissue engineering strategies. Diﬀerent architectures of
artiﬁcial neural networks with back propagation algorithm were tested to obtain the best model conﬁguration for the prediction
of the tissue engineering strategies. In the computational experiments, the artiﬁcial neural networks with one and two hidden layers
could, respectively, detect unsuccessful strategies with the highest predictive accuracy of 91.45 and 94.24%. In conclusion, artiﬁcial
intelligence has great potential in tissue engineering decision support. It can provide accurate advisory information for tissue engi-
neers, thus reducing failures and improving therapeutic eﬀects.
 2005 Elsevier Inc. All rights reserved.
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Coronary and peripheral vascular diseases represent
a growing health and socio-economic burden in most
developed countries [1,2]. Surgical bypass with vein re-
mains the majority of treatment [3,4]. However, usable
vein is often absent [5,6]. Expanded polytetraﬂuoroeth-
ylene (ePTFE) and Dacron (polyethylene terephtalate ﬁ-
bre) are the most widely used synthetic materials.
Although successful in large diameter (>5 mm) high-
ﬂow vessels, in low ﬂow or smaller diameter sites they
are compromised by both thrombogenicity and compli-
ance mismatch [7,8]. Tissue engineering represents a1532-0464/$ - see front matter  2005 Elsevier Inc. All rights reserved.
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Hei Long Jiang 150026, PR China.promising concept of applying the principles and meth-
ods of engineering and biology to develop functional tis-
sue for surgical replacement [9]. Initial attempts to
create tissue-engineered blood vessels resulted in the
manufacturing of grafts with poor mechanical proper-
ties [10,11]. Dynamic mechanical conditioning had dra-
matically improved the mechanical properties of tissue-
engineered blood vessels.
Still, many challenges remain and are currently being
addressed, particularly with regard to thrombogenicity
and the improvement of graft mechanical properties in
a limited period. When a tissue engineering strategy is
appropriate for speciﬁc patient, the result is often satis-
fying. However, the determination of strategies for vas-
cular tissue engineering can be very complicated. As the
seed cells, scaﬀolds, growth factors, bioreactor setting,
and operation methods are all highly variable, there
can be numerous strategies for speciﬁc patient. But
418 J. Xu et al. / Journal of Biomedical Informatics 38 (2005) 417–421which is the most appropriate? No one can answer this
question. Although informatics has been applied in the
course of scaﬀold design and biomimetic modeling
[12,13], no informatics tool has been developed for the
determination of tissue engineering strategies. In this
study, we used artiﬁcial neural networks to provide
advisory information for tissue engineering experiment
designers. The dataset was based on experimental re-
cords, and 36 variables were established to describe
the features of tissue engineering strategies. Artiﬁcial
neural networks with back propagation algorithm were
trained and then used to predict the outcomes of vascu-
lar tissue engineering strategies.2. Materials and methods
2.1. Vascular tissue engineering strategy
One tissue engineering strategy includes many exper-
imental processes, which are basic for extracting features
to predict the experimental result. As an example, one
strategy for tissue engineered canine carotid (with
smooth muscle cells, allogenic acelluarized matrix, and
perfusion bioreactor) can be described below:
Carotid smooth muscle cells were isolated from the
canine saphenous vein and used at low passage to seed
on the acelluarized matrix of allogenic canine carotids.
Acellularized matrix of carotid arteries were obtained
by a 0.25% trypsin and 0.02% EDTA solution for
176 h, secondary to be freeze-dried, and then used ﬁbro-
nectin as lining. The smooth muscle cells were seeded
both through the lumen and on the external surface by
a dual syringe pump under dynamic conditions. After
24 h of static culture, the construct was mounted in
the bioreactor for mechanical stimulation. The pulsatile
ﬂow in the construct was started with a peak pressure of
25 mmHg and a trough pressure of 10 mmHg. In the
second week, the pressure was increased to 60/
35 mmHg; and in the third week, the pressure was set
at 120/70 mmHg. The ﬂow rates inside and outside the
constructs were, respectively, kept at 45 ml/min and
4 ml/h. The construct was cultured for 21 days in the
bioreactor and implanted in the dog. After 2 months,
the experimental result was examined. If the carotid is
fully reconstructed (with normal histological and
mechanical properties, without thrombus), the result is
‘‘successful.’’
As for other strategies, the experimental processes
(e.g., seed cells, scaﬀolds, growth factors, bioreactor set-
ting, and operation methods) may be diﬀerent.
2.2. Data preparation
The experimental records for canine carotid tissue
engineering was provided by the Tissue EngineeringLaboratory of Harbin Medical University (founded in
1998), and altogether 36 variables were used as features
of the recipients, the tissue engineering strategies and the
results (Table 1). The dataset includes 450 dogs treated
with tissue-engineered carotids. The variable ‘‘Result’’
denoted the outcomes of tissue engineering strategies,
and other 35 variables were selected as features of dogs
and tissue engineering strategies.
Before ANNs and decision trees were trained, a 1-of-
C encoding (one binary variable per class) was applied
to the nominal attributes with few diﬀerent values. For
example, the scaﬀold of polyglycolic acid polymer, colla-
gen gel, and polyurethane were denoted with 001, 010,
and 100. The ‘‘Result’’ variable was denoted with 0
and 1, according to the scheme: successful reconstruc-
tion (with normal histological and mechanical proper-
ties, without thrombus)ﬁ 0 (negative); failed
reconstruction (with abnormal histological or mechani-
cal properties, or with thrombus)ﬁ 1 (positive).
Because the numerical variables have very diﬀerent
orders of magnitude, they were rescaled to be included
within the interval [0,1] by using the following equation:
V n ¼ V o  V minV max  V min ð1Þ
in which Vo and Vn are, respectively, the old and new va-
lue of the variable, Vmin and Vmax are the minimum and
maximum values of that variable in the original dataset.
In this work, three accuracy measures were used: the
true positive rate (PR), also known as sensitivity, the
true negative rate (NR), also known as speciﬁcity, and
the predictive accuracy (PA), which gives an overall
evaluation. The accuracy measures can be computed
with True Positive (TP), true negative (TN), false posi-
tive (FP), and false negative (FN) as following:
PR ¼ TP
FNþ TP 100ð%Þ;
NR ¼ TN
TNþ FP 100ð%Þ;
PA ¼ TNþ TP
TNþ FPþ FNþ TP 100ð%Þ:
ð2Þ
A cross-validation method (K-fold cross-validation)
was used to prepare training and test datasets. The
450 records were randomly cut into ﬁve (i.e., K = 5)
parts, with four of ﬁve parts used as training data and
the remaining part used as test data each time. For
example, for the ﬁrst set, parts one to four were used
for the training data and part ﬁve for test data; and
for the second set, part one, two, three, and ﬁve were
used for training data and part four for test data, and
so on. The ﬁnal predictive accuracy (PA) was the aver-
age of the ﬁve test samples. Standard deviations (SD)
of the ﬁve test samples were also showed. The dataset
was randomly cut for 20 times, and each time a cross-
validation was implemented. The PA with the smallest
Table 1
Variables for describing strategies
Categories Variables
Features of the dog Physiological Gender, age, weight, development, nutrition, etc.
Pathological Diameter, strength, and thickness of the lost vessel; Existence of Organ failure, tumor,
infection, wound, immunodeﬁciency, metabolic disorders, etc.
Tissue engineering strategies Seed Cells Smooth muscle cells, endothelial cells, Embryonic stem cells, embryonic germ cells, adult
stem cells or their diﬀerentiated lineages, gene-modiﬁed cells, etc.
Scaﬀolds Acelluarized matrix, polymeric substances, PGA, collagen, etc; porosity, pore size, etc;
Growth factors VEGF, PDGF, etc; origin, quantity, etc.
Bioreactors Flow rate, pulsate rate, pressure, deformation, etc.
Operation Cultural time, media concentrate, etc.
Result Successful, failed
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the statistical analysis, a value of P < 0.05 was accepted
as signiﬁcant.
2.3. Artiﬁcial neural networks
The artiﬁcial neural networks (ANNs) with back
propagation algorithm has been utilized in most of the
neural networks applications [14–16]. In this study, dif-
ferent neural network architectures were tested to obtain
the best model conﬁguration for the prediction of the
tissue engineering strategies. The modeling method
was based on the principles of the backpropagation
algorithm (Rumelhart et al., 1986) [17]. A backpropaga-
tion network typically comprises three types of neuron
layers: an input layer, one or more hidden layers, and
an output layer each including one or several neurons.
As shown in Fig. 1, nodes from one layer are connected
to all nodes in the following layer, but no lateral connec-
tions within any layer, nor feed-back connections are
possible. We compared the predictive accuracy of ANNs
that had diﬀerent hidden layers, neuron numbers, and
training epochs. The computational test was carriedFig. 1. Illustration of a four-layered neural network with one input
layer, two hidden layer and one output layer.out with one widely available commercial software pro-
gram (Matlab).3. Results
In the cross-validation procedure (which was carried
20 times in this study), the classiﬁcation model was more
precise as the standard deviation becomes smaller. Thus,
the performance of speciﬁc classiﬁer was denoted by pre-
dictive accuracy with the smallest standard deviation. As
shown in Table 2, the artiﬁcial neural networks with two
hidden layers performed better and achieved the predic-
tive accuracy of 94.24%, which was signiﬁcantly higher
than that of artiﬁcial neural networks with one hidden
layer (t test, P < 0.05).
3.1. Optimization of the artiﬁcial neural networks with
one hidden layer
The predictive accuracy varied with the number of
hidden neurons and the maximum training epochs (as
shown in Table 3 and Fig. 2). After experimental trails,
the number of hidden neurons was set to 8, being the
maximum number of epochs set to 4000. The resultant
predictive accuracy was 91.45% (the highest in all
groups), and the relevant sensitivity (PR) and speciﬁcity
(NR) were, respectively, 92.37 and 90.71%.
3.2. Optimization of the artiﬁcial neural networks with
two hidden layers
Neural networks with diﬀerent training epochs and
diﬀerent numbers of neurons in the ﬁrst and secondTable 2
The predictive accuracy achieved by ANNs with diﬀerent hidden layers
Artiﬁcial neural networks
One hidden layer Two hidden layers
PA ± SDa 91.45% ± 1.26% 94.24% ± 1.08%
a PA, predictive accuracy; SD, standard deviation.
Table 3
ANNs with one hidden layer
Training epochs Number of hidden neurons
3 4 5 6 7 8 9 10
1000 0.7196 0.7281 0.7512 0.7615 0.7531 0.7494 0.7410 0.7477
2000 0.7458 0.7667 0.7852 0.8169 0.8225 0.8071 0.7865 0.7508
3000 0.7438 0.7898 0.8040 0.8163 0.8417 0.8687 0.8198 0.8540
4000 0.8294 0.8008 0.8596 0.8221 0.8462 0.9145 0.8519 0.8444
5000 0.7223 0.7644 0.8262 0.8429 0.8319 0.8747 0.8167 0.8263
6000 0.7346 0.8063 0.8450 0.8619 0.8058 0.8344 0.8035 0.7881
7000 0.7854 0.8025 0.7748 0.8423 0.8117 0.8490 0.7337 0.8283
The predictive accuracy varied with the number of hidden neurons and the maximum training epochs.
Fig. 2. ANNs with one hidden layer. The prediction accuracy varied
with the number of hidden neurons and training epochs. It can also be
seen that the neural network with 8 hidden neurons and 4000 training
epochs achieved the highest PA of 91.45% (as labeled by the arrow).
Fig. 3. ANNs with two hidden layers, the prediction accuracy varied
with the numbers of neurons in the two hidden layers. The ANN with
respectively 6 and 3 neurons in the ﬁrst and the second hidden layers
achieved the highest PA of 0.9424.
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of neurons in the two hidden layers all ranged from 2 to
8, resulting in 49 network architectures. The most
appropriate training epoch for speciﬁc architecture was
searched in the range of 2000–20,000. After experimen-
tal trails, a neural network with, respectively, 6 and 3
neurons in the ﬁrst and second hidden layers achieved
the highest predictive accuracy of 94.24% (as shown inTable 4
ANNs with two hidden layers, the predictive accuracy varied with the numb
N2
a Number of neurons in the ﬁrst hidden layer
2 3 4
2 0.7889 0.7981 0.8068
3 0.7847 0.8023 0.8223
4 0.8139 0.7835 0.8352
5 0.8264 0.7953 0.8977
6 0.8081 0.8177 0.8806
7 0.8085 0.8239 0.8343
8 0.7835 0.7743 0.8118
a N2: the number of neurons in the second hidden layer.Table 4 and Fig. 3). The training epoch was set to
13,000, and the relevant sensitivity (PR) and speciﬁcity
(NR) were, respectively, 95.08 and 93.56%.4. Discussion and conclusions
Although tissue engineering progressed rapidly in the
past 20 years, tissue engineers are often very confuseders of neurons in the ﬁrst and second hidden layers
5 6 7 8
0.8160 0.8848 0.8764 0.8348
0.8377 0.9424 0.8884 0.8764
0.8648 0.9185 0.8956 0.8685
0.9206 0.9064 0.8852 0.8593
0.8502 0.8781 0.8702 0.8672
0.8388 0.8202 0.8389 0.8446
0.8305 0.8481 0.8243 0.8164
J. Xu et al. / Journal of Biomedical Informatics 38 (2005) 417–421 421on ﬁnding the most appropriate strategy for speciﬁc pa-
tient. Unfortunately, no decision support systemhas been
developed to solve this problem, leaving the adoption of
strategies at the discretion of experiment designers. Safety
and eﬀectiveness have been the biggest hurdles in the clin-
ical application of tissue engineered products (especially
the vessels). Thus, there is an urgent need for methods
of determination in vascular tissue engineering.
In this study, we have used artiﬁcial neural networks
to predict the outcomes of diﬀerent vascular tissue engi-
neering strategies. In the computational experiments,
the artiﬁcial neural networks with two hidden layers
could identify improper strategies with the predictive
accuracy of 94.24%. Thus, a prompt alarm could be gi-
ven to tissue engineers before the improper strategy
really run failed. The high predictive accuracy of artiﬁ-
cial neural networks may due to its capability of gener-
alization of nonlinearly separable problems.
This work has proved that artiﬁcial intelligence has
great potential in tissue engineering decision support.
It can provide accurate advisory information for tissue
engineers, thus reducing failures and improving thera-
peutic eﬀects. In contrast to human intelligence, the arti-
ﬁcial intelligent system can study larger dataset and
make more precise decision. Artiﬁcial intelligence can
eﬀectively reduce the risk of tissue engineering, and thus,
hopefully, making tissue engineering accepted earlier by
the medical market.
In future research, we plan to predict the strategies
for other tissue types (e.g., skin, tendon, and cornea),
thus raveling the applicability of this method in the
whole realm. Another interesting direction is based in
the use of further data mining tools on more species,
especially human being.References
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